Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03639311
Brief Title: Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study

First Submitted : August 10, 2018
First Submitted that Met QC Criteria : August 20, 2018
First Posted : August 21, 2018

Results First Submitted : November 20, 2020
Results First Submitted that Met QC Criteria : January 13, 2021
Results First Posted : January 15, 2021

Last Update Submitted that Met QC Criteria : February 23, 2021
Last Update Posted : March 22, 2021